Heart Failure With Nonischemic Cardiomyopathy

1 clinical trials · Condition

Record	Firm	Date
Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL) (NCT04490681)	Yonsei University	2020-08-01

Every clearance here is in the API, with alerts when new ones post.